识别和治疗脆弱的动脉样硬化斑块
John A Ambrose1, Avinash V Sharma1
1Division of Cardiology, Department of Medicine, UCSF Fresno Medical Education Program, Fresno, California.
The American journal of cardiology
|August 23, 2023
概括
识别导致急性冠状动脉综合征的脆弱斑块是关键. 新的成像技术有助于检测这些非阻塞性,高风险斑块,用于预防心肌梗塞的预防策略.
科学领域:
- 心脏病学 心脏病学
- 血管生物学 血管生物学
- 医疗成像医学成像
背景情况:
- 急性冠状动脉综合征往往是冠状动脉血栓在破坏或侵蚀的动脉样硬化斑块上的结果.
- 这些易受伤害的斑块,通常非阻塞性,是心肌梗塞和心脏突然死亡的主要原因.
- 传统的心脏病学专注于阻塞性病变,忽视脆弱的斑块.
研究的目的:
- 探索易受伤害,易发生血栓的斑块的识别和管理.
- 讨论针对无症状高危斑块的新型预防策略.
- 对管理这些病变的非侵入性和干预性方法进行审查.
主要方法:
- 使用计算机断层血管造影 (CTA) 识别易受伤害的斑块.
- 在侵袭性冠状动脉血管造影期间使用血管内成像来检测斑块.
- 分析患者管理的非侵入性技术和全身疗法.
主要成果:
- 在症状出现之前,CTA和血管内成像可以识别大多数易受伤害的斑块.
- 这些成像模式可以检测非阻塞性,但具有高风险的斑块.
- 基于早期斑块识别,可以制定新的预防策略.
结论:
- 识别易受损伤的斑块对于预防心肌梗塞等血栓事件至关重要.
- 非侵入性和全身疗法为治疗这些病变的患者提供了途径.
- 一个新的干预范式可能会出现,用于治疗易发生血栓的斑块.
更多相关视频
相关概念视频
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Atherosclerosis IV: Nursing Management
22
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
22
Atherosclerosis I: Introduction
10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Coronary Artery Disease IV: Preventive Measures
23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23


